Home/Filings/4/0001415889-24-007182
4//SEC Filing

Borgman Anne Elizabeth 4

Accession 0001415889-24-007182

CIK 0001382101other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:24 PM ET

Size

8.1 KB

Accession

0001415889-24-007182

Insider Transaction Report

Form 4
Period: 2024-03-05
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2024-03-05+60,00060,000 total
    Exercise: $4.54Exp: 2034-03-05Common Stock (60,000 underlying)
  • Award

    Restricted Stock Units (RSUs)

    2024-03-05+45,00045,000 total
    Exp: 2028-03-01Common Stock (45,000 underlying)
Footnotes (3)
  • [F1]The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
  • [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001886388

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:24 PM ET
Size
8.1 KB